Report Detail

Medical Devices & Consumables Global Insulin Injection Devices Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4704893
  • |
  • 01 June, 2026
  • |
  • Global
  • |
  • 133 Pages
  • |
  • GIR
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Insulin Injection Devices market size was valued at US$ 12810 million in 2025 and is forecast to a readjusted size of US$ 16380 million by 2032 with a CAGR of 3.6% during review period.
The driving factors for insulin injection equipment mainly include the following aspects:
Growth in the prevalence of diabetes: As the prevalence of diabetes continues to grow globally, the number of patients requiring insulin treatment is also increasing, which directly drives the market demand for insulin injection equipment.
Need for Insulin Treatment: Insulin is an important drug in the treatment of diabetes and requires regular injections to control blood sugar levels. Therefore, the demand for insulin injection equipment is also increasing.
Convenience and safety of disposable needles: The use of disposable needles reduces the risk of infection, is easy to handle, and is convenient to carry, which makes them popular in the insulin injection equipment market.
Advances in medical technology: With the continuous advancement of medical technology, insulin injection equipment is also constantly improving and innovating, improving the convenience and safety of use, further promoting market demand.
This report is a detailed and comprehensive analysis for global Insulin Injection Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Insulin Injection Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Insulin Injection Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Insulin Injection Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Insulin Injection Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Insulin Injection Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Insulin Injection Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Apex Medical, BD, Tonghua Dongbao Pharmaceutical, Eli Lilly, Biocon Ltd, Ganlee, Insulet, LenoMed Medical, Maishitong, Medtronic, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Insulin Injection Devices market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Insulin Pump
Insulin Pen
Insulin Syringe
Others
Market segment by Application
Hospital
Clinic
Pharmacy
Major players covered
Apex Medical
BD
Tonghua Dongbao Pharmaceutical
Eli Lilly
Biocon Ltd
Ganlee
Insulet
LenoMed Medical
Maishitong
Medtronic
MicroTech Medical
Novo Nordisk
Owen Mumford
Zhengzhou Phray Technology
Sanofi
SOOIL
Tandem
Ypsomed Holding
Abbott Laboratories
FORNIA
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Insulin Injection Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Insulin Injection Devices, with price, sales quantity, revenue, and global market share of Insulin Injection Devices from 2021 to 2026.
Chapter 3, the Insulin Injection Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Insulin Injection Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Insulin Injection Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Insulin Injection Devices.
Chapter 14 and 15, to describe Insulin Injection Devices sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Insulin Injection Devices Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Insulin Pump
    • 1.3.3 Insulin Pen
    • 1.3.4 Insulin Syringe
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Insulin Injection Devices Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Pharmacy
  • 1.5 Global Insulin Injection Devices Market Size & Forecast
    • 1.5.1 Global Insulin Injection Devices Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Insulin Injection Devices Sales Quantity (2021-2032)
    • 1.5.3 Global Insulin Injection Devices Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Apex Medical
    • 2.1.1 Apex Medical Details
    • 2.1.2 Apex Medical Major Business
    • 2.1.3 Apex Medical Insulin Injection Devices Product and Services
    • 2.1.4 Apex Medical Insulin Injection Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Apex Medical Recent Developments/Updates
  • 2.2 BD
    • 2.2.1 BD Details
    • 2.2.2 BD Major Business
    • 2.2.3 BD Insulin Injection Devices Product and Services
    • 2.2.4 BD Insulin Injection Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 BD Recent Developments/Updates
  • 2.3 Tonghua Dongbao Pharmaceutical
    • 2.3.1 Tonghua Dongbao Pharmaceutical Details
    • 2.3.2 Tonghua Dongbao Pharmaceutical Major Business
    • 2.3.3 Tonghua Dongbao Pharmaceutical Insulin Injection Devices Product and Services
    • 2.3.4 Tonghua Dongbao Pharmaceutical Insulin Injection Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
  • 2.4 Eli Lilly
    • 2.4.1 Eli Lilly Details
    • 2.4.2 Eli Lilly Major Business
    • 2.4.3 Eli Lilly Insulin Injection Devices Product and Services
    • 2.4.4 Eli Lilly Insulin Injection Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Eli Lilly Recent Developments/Updates
  • 2.5 Biocon Ltd
    • 2.5.1 Biocon Ltd Details
    • 2.5.2 Biocon Ltd Major Business
    • 2.5.3 Biocon Ltd Insulin Injection Devices Product and Services
    • 2.5.4 Biocon Ltd Insulin Injection Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Biocon Ltd Recent Developments/Updates
  • 2.6 Ganlee
    • 2.6.1 Ganlee Details
    • 2.6.2 Ganlee Major Business
    • 2.6.3 Ganlee Insulin Injection Devices Product and Services
    • 2.6.4 Ganlee Insulin Injection Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Ganlee Recent Developments/Updates
  • 2.7 Insulet
    • 2.7.1 Insulet Details
    • 2.7.2 Insulet Major Business
    • 2.7.3 Insulet Insulin Injection Devices Product and Services
    • 2.7.4 Insulet Insulin Injection Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Insulet Recent Developments/Updates
  • 2.8 LenoMed Medical
    • 2.8.1 LenoMed Medical Details
    • 2.8.2 LenoMed Medical Major Business
    • 2.8.3 LenoMed Medical Insulin Injection Devices Product and Services
    • 2.8.4 LenoMed Medical Insulin Injection Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 LenoMed Medical Recent Developments/Updates
  • 2.9 Maishitong
    • 2.9.1 Maishitong Details
    • 2.9.2 Maishitong Major Business
    • 2.9.3 Maishitong Insulin Injection Devices Product and Services
    • 2.9.4 Maishitong Insulin Injection Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Maishitong Recent Developments/Updates
  • 2.10 Medtronic
    • 2.10.1 Medtronic Details
    • 2.10.2 Medtronic Major Business
    • 2.10.3 Medtronic Insulin Injection Devices Product and Services
    • 2.10.4 Medtronic Insulin Injection Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Medtronic Recent Developments/Updates
  • 2.11 MicroTech Medical
    • 2.11.1 MicroTech Medical Details
    • 2.11.2 MicroTech Medical Major Business
    • 2.11.3 MicroTech Medical Insulin Injection Devices Product and Services
    • 2.11.4 MicroTech Medical Insulin Injection Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 MicroTech Medical Recent Developments/Updates
  • 2.12 Novo Nordisk
    • 2.12.1 Novo Nordisk Details
    • 2.12.2 Novo Nordisk Major Business
    • 2.12.3 Novo Nordisk Insulin Injection Devices Product and Services
    • 2.12.4 Novo Nordisk Insulin Injection Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Novo Nordisk Recent Developments/Updates
  • 2.13 Owen Mumford
    • 2.13.1 Owen Mumford Details
    • 2.13.2 Owen Mumford Major Business
    • 2.13.3 Owen Mumford Insulin Injection Devices Product and Services
    • 2.13.4 Owen Mumford Insulin Injection Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Owen Mumford Recent Developments/Updates
  • 2.14 Zhengzhou Phray Technology
    • 2.14.1 Zhengzhou Phray Technology Details
    • 2.14.2 Zhengzhou Phray Technology Major Business
    • 2.14.3 Zhengzhou Phray Technology Insulin Injection Devices Product and Services
    • 2.14.4 Zhengzhou Phray Technology Insulin Injection Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Zhengzhou Phray Technology Recent Developments/Updates
  • 2.15 Sanofi
    • 2.15.1 Sanofi Details
    • 2.15.2 Sanofi Major Business
    • 2.15.3 Sanofi Insulin Injection Devices Product and Services
    • 2.15.4 Sanofi Insulin Injection Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Sanofi Recent Developments/Updates
  • 2.16 SOOIL
    • 2.16.1 SOOIL Details
    • 2.16.2 SOOIL Major Business
    • 2.16.3 SOOIL Insulin Injection Devices Product and Services
    • 2.16.4 SOOIL Insulin Injection Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 SOOIL Recent Developments/Updates
  • 2.17 Tandem
    • 2.17.1 Tandem Details
    • 2.17.2 Tandem Major Business
    • 2.17.3 Tandem Insulin Injection Devices Product and Services
    • 2.17.4 Tandem Insulin Injection Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Tandem Recent Developments/Updates
  • 2.18 Ypsomed Holding
    • 2.18.1 Ypsomed Holding Details
    • 2.18.2 Ypsomed Holding Major Business
    • 2.18.3 Ypsomed Holding Insulin Injection Devices Product and Services
    • 2.18.4 Ypsomed Holding Insulin Injection Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Ypsomed Holding Recent Developments/Updates
  • 2.19 Abbott Laboratories
    • 2.19.1 Abbott Laboratories Details
    • 2.19.2 Abbott Laboratories Major Business
    • 2.19.3 Abbott Laboratories Insulin Injection Devices Product and Services
    • 2.19.4 Abbott Laboratories Insulin Injection Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Abbott Laboratories Recent Developments/Updates
  • 2.20 FORNIA
    • 2.20.1 FORNIA Details
    • 2.20.2 FORNIA Major Business
    • 2.20.3 FORNIA Insulin Injection Devices Product and Services
    • 2.20.4 FORNIA Insulin Injection Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 FORNIA Recent Developments/Updates

3 Competitive Environment: Insulin Injection Devices by Manufacturer

  • 3.1 Global Insulin Injection Devices Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Insulin Injection Devices Revenue by Manufacturer (2021-2026)
  • 3.3 Global Insulin Injection Devices Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Insulin Injection Devices by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Insulin Injection Devices Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Insulin Injection Devices Manufacturer Market Share in 2025
  • 3.5 Insulin Injection Devices Market: Overall Company Footprint Analysis
    • 3.5.1 Insulin Injection Devices Market: Region Footprint
    • 3.5.2 Insulin Injection Devices Market: Company Product Type Footprint
    • 3.5.3 Insulin Injection Devices Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Insulin Injection Devices Market Size by Region
    • 4.1.1 Global Insulin Injection Devices Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Insulin Injection Devices Consumption Value by Region (2021-2032)
    • 4.1.3 Global Insulin Injection Devices Average Price by Region (2021-2032)
  • 4.2 North America Insulin Injection Devices Consumption Value (2021-2032)
  • 4.3 Europe Insulin Injection Devices Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Insulin Injection Devices Consumption Value (2021-2032)
  • 4.5 South America Insulin Injection Devices Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Insulin Injection Devices Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Insulin Injection Devices Sales Quantity by Type (2021-2032)
  • 5.2 Global Insulin Injection Devices Consumption Value by Type (2021-2032)
  • 5.3 Global Insulin Injection Devices Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Insulin Injection Devices Sales Quantity by Application (2021-2032)
  • 6.2 Global Insulin Injection Devices Consumption Value by Application (2021-2032)
  • 6.3 Global Insulin Injection Devices Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Insulin Injection Devices Sales Quantity by Type (2021-2032)
  • 7.2 North America Insulin Injection Devices Sales Quantity by Application (2021-2032)
  • 7.3 North America Insulin Injection Devices Market Size by Country
    • 7.3.1 North America Insulin Injection Devices Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Insulin Injection Devices Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Insulin Injection Devices Sales Quantity by Type (2021-2032)
  • 8.2 Europe Insulin Injection Devices Sales Quantity by Application (2021-2032)
  • 8.3 Europe Insulin Injection Devices Market Size by Country
    • 8.3.1 Europe Insulin Injection Devices Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Insulin Injection Devices Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Insulin Injection Devices Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Insulin Injection Devices Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Insulin Injection Devices Market Size by Region
    • 9.3.1 Asia-Pacific Insulin Injection Devices Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Insulin Injection Devices Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Insulin Injection Devices Sales Quantity by Type (2021-2032)
  • 10.2 South America Insulin Injection Devices Sales Quantity by Application (2021-2032)
  • 10.3 South America Insulin Injection Devices Market Size by Country
    • 10.3.1 South America Insulin Injection Devices Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Insulin Injection Devices Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Insulin Injection Devices Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Insulin Injection Devices Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Insulin Injection Devices Market Size by Country
    • 11.3.1 Middle East & Africa Insulin Injection Devices Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Insulin Injection Devices Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Insulin Injection Devices Market Drivers
  • 12.2 Insulin Injection Devices Market Restraints
  • 12.3 Insulin Injection Devices Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Insulin Injection Devices and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Insulin Injection Devices
  • 13.3 Insulin Injection Devices Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Insulin Injection Devices Typical Distributors
  • 14.3 Insulin Injection Devices Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Insulin Injection Devices. Industry analysis & Market Report on Insulin Injection Devices is a syndicated market report, published as Global Insulin Injection Devices Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Insulin Injection Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report